tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IMTX Stock Latest News

Immatics Reveals Promising IMA401 Trial Results
Company AnnouncementsImmatics Reveals Promising IMA401 Trial Results
4d ago
6K
IMTX
Immatics presents TCER IMA401 data at ESMO
PremiumThe Fly
Immatics presents TCER IMA401 data at ESMO
4d ago
IMTX
Immatics collaboration with Bristol Myers ends due to portfolio prioritization
PremiumThe Fly
Immatics collaboration with Bristol Myers ends due to portfolio prioritization
4d ago
BMY
IMTX
Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER® IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update
PremiumPress Releases
Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER® IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update
4d ago
IMTX
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
PremiumPress Releases
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
14d ago
IMTX
Immatics N.V. Unveils Mid-Year Financial Outlook
PremiumCompany AnnouncementsImmatics N.V. Unveils Mid-Year Financial Outlook
1M ago
6K
IMTX
Immatics sees cash runway into 2027
Premium
The Fly
Immatics sees cash runway into 2027
1M ago
IMTX
Immatics reports Q2 EPS (EUR 0.17) vs. (EUR 0.32) last year
Premium
The Fly
Immatics reports Q2 EPS (EUR 0.17) vs. (EUR 0.32) last year
1M ago
IMTX
Immatics N.V. Appoints New Board Member
PremiumCompany Announcements
Immatics N.V. Appoints New Board Member
2M ago
6K
IMTX
Immatics appoints Reicin to board of directors
PremiumThe Fly
Immatics appoints Reicin to board of directors
2M ago
IMTX
TECX
Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024
PremiumPress Releases
Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024
2M ago
IMTX
Immatics N.V. AGM Concludes Successfully
PremiumCompany Announcements
Immatics N.V. AGM Concludes Successfully
3M ago
6K
IMTX
Immatics N.V. Schedules 2024 Annual Meeting
PremiumCompany AnnouncementsImmatics N.V. Schedules 2024 Annual Meeting
4M ago
6K
IMTX
Immatics price target raised to $16 from $14 at Mizuho
Premium
The Fly
Immatics price target raised to $16 from $14 at Mizuho
4M ago
IMTX
Immatics N.V. Q1 Financials Show Net Loss Shrinkage
Premium
Company Announcements
Immatics N.V. Q1 Financials Show Net Loss Shrinkage
4M ago
6K
IMTX
Immatics reports Q1 EPS (EUR 0.04) vs (EUR 0.26) last year
PremiumThe Fly
Immatics reports Q1 EPS (EUR 0.04) vs (EUR 0.26) last year
4M ago
IMTX
IMTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
IMTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
IMTX
Immatics N.V. Showcases Clinical Strides and Fiscal Health
PremiumCompany Announcements
Immatics N.V. Showcases Clinical Strides and Fiscal Health
6M ago
6K
IMTX
Immatics sees cash runway into 2027
PremiumThe Fly
Immatics sees cash runway into 2027
6M ago
IMTX
Immatics reports 2023 EPS (EUR 1.20) vs. EUR 0.55 last year
PremiumThe FlyImmatics reports 2023 EPS (EUR 1.20) vs. EUR 0.55 last year
6M ago
IMTX
Is IMTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is IMTX a Buy, Before Earnings?
6M ago
IMTX
Immatics 15.925M share Spot Secondary priced at $11.00
Premium
The Fly
Immatics 15.925M share Spot Secondary priced at $11.00
8M ago
IMTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >